Two potentially lifesaving blood-pressure drugs could be causing more harm than good, according to a recall notice posted by the U.S. Food and Drug Administration (FDA). Lupin Pharmaceuticals ...

Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg because ...

Two types of blood pressure medication made by the company Lupin Pharmaceuticals are being recalled because they may contain high levels of a substance that could cause cancer. The Food and Drug ...

BALTIMORE, Md. - A Lupin Pharmaceuticals Inc. blood pressure medication is being recalled by the U.S. Food and Drug Administration (FDA) for potentially containing a "probable human carcinogen." The ...

Lupin Pharmaceuticals is voluntarily recalling several batches of two blood-pressure drugs with high levels of a known carcinogen, per the FDA. Certain Irbesartan tablets and Irbesartan and ...

Lupin Pharmaceuticals and the Food and Drug Administration have announced a recall of batches of irbesartan tablets and irbesartan hydrochlorothiazide tablets, used to treat high blood pressure. Some ...

(NEXSTAR) – Lupin Pharmaceuticals Inc. is voluntarily recalling a blood pressure medication that possibly contains high levels of a cancer-causing impurity, according to the U.S. Food and Drug ...

Lupin Pharmaceuticals is voluntarily recalling certain dosages of irbesartan tablets and irbesartan and hydrochlorothiazide tablets distributed in... Two types of blood pressure medication made by the ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (NEXSTAR) – Lupin Pharmaceuticals Inc. is ...